Skip to main content
. 2024 Sep 9;22(Suppl 2):83. doi: 10.1186/s12969-024-01005-y

Table 1 (abstract PReS24-ABS-1185).

General features of the cohort

Overall (N=114) No recurrences (N=61 pts) Recurrences (N=53 pts) p
Age, years, mean (sd) 12 (3.9) 12 (4) 12 (3.8) 0.81
Ethnicity 0.03
 Caucasian 74 (65%) 34 (55%) 40 (75%)
 Non-Caucasian 40 (35%) 27 (45%) 13 (25%)
Diagnosis 0.51
 Idiopathic Uveitis 46 (40%) 22 (36%) 24 (45%)
 Juvenile idiopathic arthritis 52 (46%) 28 (46%) 24 (45%)
 Other 16 (14%) 11 (18%) 5 (10%)
Inactivity before adalimumab taper onset, weeks, mean (sd) 163 (174) 189 (200) 133 (132) 0.72